• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Medtronic is telling workers to return to the office more

Medtronic is telling workers to return to the office more

May 30, 2025 By Chris Newmarker

This a Medtronic image of the statue in front of its operational headquarters in Fridley, Minnesota.
The front of Medtronic’s operational headquarters in Fridley, Minnesota. [Image courtesy of Medtronic]

Add Medtronic (NYSE: MDT)  to the growing list of companies and institutions rolling back the work-from-home movement that outlasted the COVID-19 pandemic.

Medtronic is increasing the in-office requirement for currently hybrid employees to four days a week from the previous three days a week, according to a Minnesota Star Tribune report.  The Star Tribune cited an internal Medtronic Executive Committee email, which said the changes will initially occur on Sept. 2 with seven U.S. locations prioritized including the medtech giant’s operational headquarters in Fridley, Minnesota.

In a statement shared with MassDevice by a spokesperson, Medtronic confirmed the move to the four-days-a-week requirement. The company said: “This decision is rooted in our belief that in-person exchanges are invaluable to our work. The collaborative energy generated through face-to-face interactions strengthens our operational efficiency and provides the support and community we need to thrive and bring life-saving technology to patients around the world.”

Many companies have sought, in fits and starts, to encourage white-collar workers to return to the office more frequently after the pandemic, but the trend accelerated early this year after President Trump signed an executive order requiring federal workers to return to the office five days a week. Companies, including Amazon and JP Morgan, have returned to five-day-a-week requirements, too.

Even the Minnesota state government, run by former Democratic vice presidential candidate Gov. Tim Walz, plans to have many of its workers show up at the office at least half of the time.

While Medtronic’s latest move aligns with recent trends, the company has also undergone rounds of restructuring, early retirement initiatives, and job cuts in recent years, as CEO Geoff Martha and other company leaders seek to boost the company’s earnings power. The initiatives have hit a bump in the road due to Trump’s trade policy, with the company announcing during its Q4 earnings report this month that tariffs were expected to have a $200–$ 350 million impact on earnings. Revenue is expected to grow around 5% in the new fiscal year.

Martha said at the time: “You can see from the significant amount that we’ve already been able to offset, that we are extremely focused on mitigating actions. You also see from our guidance that the underlying fundamentals of the business are strong, and they’re getting stronger.”

Filed Under: Business/Financial News, Featured, Wall Street Beat Tagged With: Medtronic

More recent news

  • Steris inks $2.1B deal for operating room supplier Xodus Medical
  • Insulet’s Omnipod Discover data platform begins full US rollout
  • Siemens Healthineers exits general ultrasound to focus on cardiac imaging
  • Johnson & Johnson MedTech sets mid-2027 target for ortho spinoff, as Q3 device sales disappoint
  • Olympus receives FDA warning letter after international inspections

About Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy